Maria Elena Bottazzi | Co-Director of Texas Children's Hospital Center for Vaccine Development
Baylor College of Medicine

Day 1 (20th October) @ 10:15

One Shot, Many Frontiers: Combination Vaccines for a Healthier Lifetime

• How can combination vaccines support life-course immunisation strategies and close immunity gaps at every age? 
• What standards do we need to ensure multi-antigen vaccines perform consistently without compromising safety or effectiveness? 
• Could combining priority pathogens in a single shot improve vaccine coverage, or will it introduce new barriers for uptake and delivery? 
• What strategies can we use to ensure broad accessibility of combination vaccines, including considerations around technology, adjuvants, and formulation? 
• Which pairings have the strongest potential to reduce global disease burden, especially in regions with limited resources? 

Melanie Saville, Chief Scientific Officer, PATH

×

Melanie Saville / One Shot, Many Frontiers: Combination Vaccines for a Healthier Lifetime

Melanie Saville, Chief Scientific Officer,
PATH

Melanie Saville, MBBS, is PATH’s Chief Scientific Officer. She leads PATH’s product development division, which includes a global team dedicated to the development, introduction, and scale of vaccines, medical devices, and diagnostics. Dr. Saville is a Fellow of the Academy of Medical Sciences...

CloseMore

Maria Elena Bottazzi, Co-Director of Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine

Kate O'Brien, Director, Immunization, Vaccines and Biologicals, World Health Organisation (WHO)

×

Kate O'Brien / One Shot, Many Frontiers: Combination Vaccines for a Healthier Lifetime

Kate O'Brien, Director, Immunization, Vaccines and Biologicals,
World Health Organisation (WHO)

Dr. Kate O’Brien is the Director of the Immunization, Vaccines and Biologicals (IVB) Department at the World Health Organization (WHO). In this role she is responsible for leading WHO’s vaccine and immunization strategy and implementation to advance the vision of a world where...

CloseMore

Nicola Rose, Interim Executive Director of Science and Research, MHRA

Rituparna Das, Therapeutic Area Head, Respiratory Vaccines, Moderna

Day 1 (20th October) @ 16:00

Panel: Expanding the Access & Impact of Adjuvants

• How can we overcome IP and licensing challenges to make novel adjuvants more globally accessible?   
• How can regulators harmonize approval pathways for adjuvanted vaccines without compromising safety or slowing innovation?   
• How can collaboration between academia, industry, and funders, accelerate development and equitable distribution of new adjuvants?   
• What emerging adjuvant platforms or innovative technologies are available that could transform next-generation vaccines, and what obstacles exist to their deployment?   

Day 2 (21st October) @ 14:45

Update on Hookworm Vaccine Initiative